2019冠状病毒病与心血管系统：影响与启示。 - Suppr

Suppr

超能文献

Coronavirus disease 2019 and the cardiovascular system: Impacts and implications.

作者信息

Gupta Mohit D, Girish M P, Yadav Geetika, Shankar Abhishek, Yadav Rakesh

机构信息

GB Pant Institute of Post Graduate Medical Education and Research, Delhi, India.

Scientist E, ICMR, Delhi, India.

出版信息

Indian Heart J. 2020 Jan-Feb;72(1):1-6. doi: 10.1016/j.ihj.2020.03.006. Epub 2020 Apr 9.

DOI:10.1016/j.ihj.2020.03.006

PMID:32423554

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7195102/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b6e/7231867/374213b5a34a/gr1.jpg

相似文献

Coronavirus disease 2019 and the cardiovascular system: Impacts and implications.2019冠状病毒病与心血管系统：影响与启示。

Indian Heart J. 2020 Jan-Feb;72(1):1-6. doi: 10.1016/j.ihj.2020.03.006. Epub 2020 Apr 9.

COVID-19 and the cardiovascular system.新型冠状病毒肺炎与心血管系统。

Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5.

COVID-19 and the Heart.新型冠状病毒肺炎与心脏

Circ Res. 2020 May 8;126(10):1443-1455. doi: 10.1161/CIRCRESAHA.120.317055. Epub 2020 Apr 7.

Effects of SARS-CoV-2 and its functional receptor ACE2 on the cardiovascular system.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）及其功能性受体血管紧张素转换酶2（ACE2）对心血管系统的影响。

Herz. 2020 Nov;45(7):659-662. doi: 10.1007/s00059-020-04989-x. Epub 2020 Oct 6.

COVID-19 and fat embolism: a hypothesis to explain the severe clinical outcome in people with obesity.新型冠状病毒肺炎与脂肪栓塞：一种解释肥胖人群严重临床结局的假说。

Int J Obes (Lond). 2020 Aug;44(8):1800-1802. doi: 10.1038/s41366-020-0624-5. Epub 2020 Jun 8.

Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体阻滞剂对无高血压的新冠患者有益吗？

Pharmacol Res. 2020 Sep;159:104959. doi: 10.1016/j.phrs.2020.104959. Epub 2020 Jun 4.

Coronavirus disease 2019 infection and the cardiovascular system.2019冠状病毒病感染与心血管系统

J Cardiovasc Med (Hagerstown). 2020 Jun;21(6):403-405. doi: 10.2459/JCM.0000000000000980.

Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).血管紧张素转化酶 2（ACE2）、严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）与 2019 冠状病毒病（COVID-19）的病理生理学。

J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10.

COVID-19 and Cardiovascular Disease.新型冠状病毒肺炎与心血管疾病。

Circulation. 2020 May 19;141(20):1648-1655. doi: 10.1161/CIRCULATIONAHA.120.046941. Epub 2020 Mar 21.

Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?2019冠状病毒病（COVID-19）：血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂是否具有双相效应？

J Am Heart Assoc. 2020 Apr 7;9(7):e016509. doi: 10.1161/JAHA.120.016509. Epub 2020 Apr 1.

引用本文的文献

Acute Effects of Facial Coverings on Anaerobic Exercise Performance in College-Aged Adults.面部遮盖物对成年大学生无氧运动表现的急性影响。

Int J Environ Res Public Health. 2022 Aug 23;19(17):10500. doi: 10.3390/ijerph191710500.

Face Masks to Combat Coronavirus (COVID-19)-Processing, Roles, Requirements, Efficacy, Risk and Sustainability.用于抗击冠状病毒（COVID-19）的口罩——加工、作用、要求、功效、风险与可持续性

Polymers (Basel). 2022 Mar 23;14(7):1296. doi: 10.3390/polym14071296.

Intriguing new faces of Covid-19: persisting clinical symptoms and cardiac effects in children.令人好奇的新冠新面貌：儿童持续存在的临床症状和心脏影响。

Cardiol Young. 2022 Jul;32(7):1085-1091. doi: 10.1017/S1047951121003693. Epub 2021 Aug 19.

A potential association between immunosenescence and high COVID-19 related mortality among elderly patients with cardiovascular diseases.免疫衰老与老年心血管疾病患者中高新冠病毒疾病相关死亡率之间的潜在关联。

Immun Ageing. 2021 Jun 1;18(1):25. doi: 10.1186/s12979-021-00234-z.

COVID 19 pandemic: Its impact on cardiovascular training and care.新冠疫情：其对心血管训练与护理的影响。

Indian Heart J. 2020 Nov-Dec;72(6):473-476. doi: 10.1016/j.ihj.2020.12.001. Epub 2020 Dec 4.

Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives.过去四十年的病毒性大流行：发病机制、健康影响和展望。

Int J Environ Res Public Health. 2020 Dec 15;17(24):9411. doi: 10.3390/ijerph17249411.

Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: An overview.在冠状病毒病（COVID-19）大流行期间的肥胖、营养不良和微量元素缺乏：概述。

Nutrition. 2021 Jan;81:111016. doi: 10.1016/j.nut.2020.111016. Epub 2020 Sep 8.

The COVID-19 pandemic: a global health crisis.新型冠状病毒肺炎大流行：全球卫生危机。

Physiol Genomics. 2020 Nov 1;52(11):549-557. doi: 10.1152/physiolgenomics.00089.2020. Epub 2020 Sep 29.

SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.SARS-CoV-2 病理生理学及其临床意义：COVID-19 药物治疗管理的综合概述。

Food Chem Toxicol. 2020 Dec;146:111769. doi: 10.1016/j.fct.2020.111769. Epub 2020 Sep 30.

COVID -19 pandemic and paediatric population with special reference to congenital heart disease.2019冠状病毒病大流行与儿童人群，特别提及先天性心脏病

Indian Heart J. 2020 May-Jun;72(3):141-144. doi: 10.1016/j.ihj.2020.06.001. Epub 2020 Jun 6.

本文引用的文献

Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19.美国心力衰竭学会/美国心脏病学会/美国心脏协会联合声明回应关于在2019冠状病毒病中使用肾素-血管紧张素-醛固酮系统拮抗剂的担忧。

J Card Fail. 2020 May;26(5):370. doi: 10.1016/j.cardfail.2020.04.013.

First cases of COVID-19 in heart transplantation from China.中国心脏移植中首例新冠病毒病病例。

J Heart Lung Transplant. 2020 May;39(5):496-497. doi: 10.1016/j.healun.2020.03.006. Epub 2020 Mar 17.

Epidemiologic and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: A descriptive survey report.2019 年冠状病毒病疫情期间武汉心脏移植受者的流行病学和临床特征：描述性调查研究报告。

J Heart Lung Transplant. 2020 May;39(5):412-417. doi: 10.1016/j.healun.2020.03.008. Epub 2020 Mar 25.

Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak.与COVID-19疫情相关的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）可能起源于穿山甲。

Curr Biol. 2020 Apr 20;30(8):1578. doi: 10.1016/j.cub.2020.03.063.

First case of COVID-19 complicated with fulminant myocarditis: a case report and insights.首例 COVID-19 合并暴发性心肌炎：病例报告及启示

Infection. 2020 Oct;48(5):773-777. doi: 10.1007/s15010-020-01424-5. Epub 2020 Apr 10.

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。

Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.

Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI.新型冠状病毒肺炎（COVID-19）大流行期间的心导管实验室考量：来自美国心脏病学会介入委员会和心血管造影和介入学会

J Am Coll Cardiol. 2020 May 12;75(18):2372-2375. doi: 10.1016/j.jacc.2020.03.021. Epub 2020 Mar 19.

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。

N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.与严重急性呼吸综合征冠状病毒1（SARS-CoV-1）相比，严重急性呼吸综合征冠状病毒2（SARS-CoV-2）在气溶胶和表面的稳定性

N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.

Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin.糖皮质激素联合人免疫球蛋白治疗冠状病毒暴发性心肌炎

Eur Heart J. 2021 Jan 7;42(2):206. doi: 10.1093/eurheartj/ehaa190.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验